Literature DB >> 9562013

Comparative efficacy of the maze procedure for restoration of atrial contraction in patients with and without giant left atrium associated with mitral valve disease.

S Yuda1, S Nakatani, F Isobe, Y Kosakai, K Miyatake.   

Abstract

OBJECTIVES: We sought to determine the effectiveness of the maze procedure for restoring atrial contraction in patients with and without giant left atrium (GLA).
BACKGROUND: Although the maze procedure has been reported to be effective for refractory atrial fibrillation, it is unknown whether this procedure can restore effective atrial contraction in patients with GLA.
METHODS: Nineteen patients with and 32 patients without GLA were studied with Doppler echocardiography before and after the maze procedure. Peak velocity and the time-velocity integral of the left ventricular diastolic filling wave during atrial contraction (A wave) and the atrial filling fraction calculated as the ratio of the time-velocity integral of the A wave to that of total diastolic filling were compared between patients with and without GLA. A peak A wave velocity > or =10 cm/s was considered to indicate echocardiographic evidence of effective atrial contraction.
RESULTS: Regular rhythm with P waves was restored in 10 patients (53%) with and 26 (81%, p < 0.05) without GLA. Four patients (21%) with and 21 patients (66%, p < 0.01) without GLA showed effective atrial contraction by echocardiography. Once atrial contraction was resumed, the degree of atrial contraction was comparable between patients with and without GLA (17+/-5% vs. 17+/-4% for atrial filling fraction at 12 months, respectively).
CONCLUSIONS: Although most patients without GLA had restored atrial contraction by the maze procedure, it was resumed in fewer patients with GLA. However, once atrial contraction was resumed, the degree of atrial contraction was comparable between patients with and without GLA. Therefore, the maze procedure may be an option in selected patients with GLA.

Entities:  

Mesh:

Year:  1998        PMID: 9562013     DOI: 10.1016/s0735-1097(98)00058-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

Review 1.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

2.  Role of the simultaneous sequential strategy for failed acute sinus restoration after modified left maze procedure for persistent atrial fibrillation with concomitant mitral surgery.

Authors:  Jen-Ping Chang; Mien-Cheng Chen; Chiung-Lun Kao; Cheng-Hsu Yang; Teng-Hung Yu; Chien-Jen Chen
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

3.  Mechanism of improvement in exercise capacity after the maze procedure combined with mitral valve surgery.

Authors:  S Yuda; S Nakatani; Y Kosakai; T Satoh; Y Goto; M Yamagishi; K Bando; S Kitamura; K Miyatake
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

4.  EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  J Arrhythm       Date:  2016-07-11

5.  MicroRNAs as Biomarkers for Acute Atrial Remodeling in Marathon Runners (The miRathon Study--A Sub-Study of the Munich Marathon Study).

Authors:  Sebastian Clauss; Reza Wakili; Bianca Hildebrand; Stefan Kääb; Eva Hoster; Ina Klier; Eimo Martens; Alan Hanley; Henner Hanssen; Martin Halle; Thomas Nickel
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

6.  Left Atrial Function after Atrial Fibrillation Cryoablation Concomitant to Minimally Invasive Mitral Valve Repair: A Pilot Study on Long-Term Results and Clinical Implications.

Authors:  Matteo Anselmino; Chiara Rovera; Giovanni Marchetto; Davide Castagno; Mara Morello; Simone Frea; Fiorenzo Gaita; Mauro Rinaldi; Gaetano Maria De Ferrari
Journal:  Medicina (Kaunas)       Date:  2019-10-21       Impact factor: 2.430

7.  Thoracoscopic surgical atrial fibrillation ablation in patients with an extremely enlarged left atrium.

Authors:  Jolien Neefs; Robin Wesselink; Nicoline W E van den Berg; Jonas S S G de Jong; Femke R Piersma; WimJan P van Boven; Antoine H G Driessen; Joris R de Groot
Journal:  J Interv Card Electrophysiol       Date:  2021-09-16       Impact factor: 1.759

8.  Giant left atrium: a review.

Authors:  Ahmed El Maghraby; Rachel Hajar
Journal:  Heart Views       Date:  2012-04

9.  Surgical Treatment of Concomitant Atrial Fibrillation: Focus onto Atrial Contractility.

Authors:  Claudia Loardi; Francesco Alamanni; Claudia Galli; Moreno Naliato; Fabrizio Veglia; Marco Zanobini; Mauro Pepi
Journal:  Biomed Res Int       Date:  2015-07-01       Impact factor: 3.411

10.  Sinus node dysfunction after surgical atrial fibrillation ablation with concomitant mitral valve surgery: Determinants and clinical outcomes.

Authors:  Darae Kim; Chi Young Shim; Geu-Ru Hong; In Jeong Cho; Seung Hyun Lee; Hyuk-Jae Chang; Sak Lee; Jong-Won Ha; Byung-Chul Chang
Journal:  PLoS One       Date:  2018-09-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.